Biogen faces Italian antitrust probe over rivalry with Sandoz for MS drugs
Biogen Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $192.23
+1.0% in 1h after detection
Post-detection moves
1h
+1.0%
1d
-0.3%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS